The invention relates to the chemistry of organic compounds to pharmacology and to medicine and pertains to the prevention and treatment of human and animal diseases associated with metabolic disorders of bone tissues and/or cartilage tissues particularly diseases of the musculoskeletal system such as osteoarthritis...
Documents
Form DPT-3-19112020-signed
Directors report as per section 134(3)-30102020
Optional Attachment-(1)-30102020
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-30102020
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-30102020
Form AOC-4-30102020_signed
Form MGT-7-27112019_signed
List of share holders, debenture holders;-26112019
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-28102019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-28102019
Directors report as per section 134(3)-28102019
Optional Attachment-(1)-28102019
Form AOC-4-28102019_signed
Form ADT-1-13102019_signed
Copy of the intimation sent by company-13102019
Copy of resolution passed by the company-13102019
Copy of written consent given by auditor-13102019
Form DPT-3-30062019
Form ADT-1-03062019_signed
Copy of written consent given by auditor-03062019
Copy of resolution passed by the company-03062019
Copy of the intimation sent by company-03062019
List of share holders, debenture holders;-18112018
Form MGT-7-18112018_signed
Form AOC-4-26102018_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-25102018
Optional Attachment-(1)-25102018
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-25102018
Directors report as per section 134(3)-25102018
List of share holders, debenture holders;-14122017